Article

Tomek, Mary, Akiyama, Toru and Dass, Crispin R (2012) Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy. Journal of Pharmacy and Pharmacology, 64 (12). pp. 1695-1702. ISSN 0022-3573 (print) 2042-7158 (online)

Clark, Jonathan C. M, Akiyama, Toru, Dass, Crispin R and Choong, Peter F. M (2010) New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis. Cancer Cell International, 10. pp. 1-10. ISSN 1475-2867

Akiyama, Toru, Choong, Peter F. M and Dass, Crispin R (2010) RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells. Clinical and Experimental Metastasis, 27 (4). pp. 207-215. ISSN 0262-0898

Akiyama, Toru, Dass, Crispin R, Shinoda, Y, Kawano, H, Tanaka, Sakae and Choong, Peter F. M (2010) Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts. Journal of Pharmacy and Pharmacology, 62 (4). pp. 470-476. ISSN 0022-3573

Broadhead, Matthew L, Akiyama, Toru, Choong, Peter F. M and Dass, Crispin R (2010) The pathophysiological role of PEDF in bone diseases. Current Molecular Medicine, 10 (3). pp. 296-301. ISSN 1566-5240

Akiyama, Toru, Dass, Crispin R, Shinoda, Yusuke, Kawano, Hirotaka, Tanaka, Sakae and Choong, Peter F. M (2010) PEDF regulates osteoclasts via osteoprotegerin and RANKL. Biochemical and Biophysical Research Communications, 391 (1). pp. 789-794. ISSN 0006-291X (print) 1090-2104 (online)

Akiyama, Toru, Dass, Crispin R and Choong, Peter F. M (2009) Bim-targeted cancer therapy: a link between drug action and underlying molecular changes. Molecular Cancer Therapeutics , 8 (12). pp. 3173-3180. ISSN 1535-7163

Akiyama, Toru, Dass, Crispin R and Choong, Peter F. M (2008) Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone- resorbing activity and apoptosis pathway. Molecular Cancer Therapeutics, 7 (11). pp. 3461-3469. ISSN 15357163